menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Neuroprotective Agents for ALS

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Scientists at many institutions are researching to find neuroprotective agents for ALS. While today's guests research focuses on other neurological diseases, he recently wrote a commentary to a published neurology article about ALS research suggesting that the properties of a drug, Taxol should also be considered in animal models researching ALS. In this segment, Dr. Mark Nolan Hill talks with Dr. William Burke about ALS and why Taxol may be a worthwhile drug to examine in animal models as a neuoroprotective agent for ALS.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Scientists at many institutions are researching to find neuroprotective agents for ALS. While today's guests research focuses on other neurological diseases, he recently wrote a commentary to a published neurology article about ALS research suggesting that the properties of a drug, Taxol should also be considered in animal models researching ALS. In this segment, Dr. Mark Nolan Hill talks with Dr. William Burke about ALS and why Taxol may be a worthwhile drug to examine in animal models as a neuoroprotective agent for ALS.

Facebook Comments

Schedule28 Mar 2024